Status:
COMPLETED
Improving the Quality of Care for Atrial Fibrillation by Promoting Patient-Centered Decision Making
Lead Sponsor:
VA Connecticut Healthcare System
Collaborating Sponsors:
Donaghue Medical Research Foundation
Yale University
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
45+ years
Phase:
PHASE1
Brief Summary
The primary aim of this proposal is to determine the effectiveness of a decision support tool on improving the process of shared decision-making for treatment on nonvalvular atrial fibrillation (NVAF)...
Detailed Description
Decision-making regarding appropriate therapy for non-valvular atrial fibrillation (NVAF) is a complex process. Different options carry with them different profiles of risks and benefits, and choosing...
Eligibility Criteria
Inclusion
- 45 years or older
- Be scheduled to see primary Doctor at VA
- Diagnosis of atrial fibrillation
- English speaking
Exclusion
- Have valvular disease as the cause of Afib
- Be on warfarin for a condition other than NVAF
- Have a contraindication to warfin
- Have a contraindication to ASA
- Life expectancy of less than 12 months
- Cognitive impairment
- Receiving anti-platelet agent other than aspirin
- Receiving care in a supervised resident clinic or from an attending physician who refuses participation in the study
- Bleed with identified source in the last 12 months
- Bleed with an unidentified source
- History of intracerebral hemorrhage
- Severe hearing impairment
- Severe visual impairment
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT00829478
Start Date
October 1 2008
End Date
June 1 2010
Last Update
March 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Connecticut Healthcare System - West Haven Campus
West Haven, Connecticut, United States, 06516